THSD7A and neoplasm: The description of patients with THSD7A-associated MN and concomitant THSD7A-expressing tumors, combined with the finding that patients with THSD7A-associated MN show a higher tumor prevalence, has led to the recommendation to more thoroughly screen patients with THSD7A-associated MN for the presence of tumors (Hoxha et al. 2016, 2017; Lin et al. 2018; Matsumoto et al. 2019; Taguchi et al. 2019; Wang et al. 2019; Weinmann-Menke et al. 2019; Xian et al. 2019; Zhang et al. 2019).